The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature.
Sign Up to like & getrecommendations! Published in 2017 at "European journal of endocrinology"
DOI: 10.1530/eje-16-0960
Abstract: BACKGROUND Liver metastases are relatively common in patients with metastatic medullary thyroid carcinoma (MTC), carrying a negative impact on disease prognosis. The options for selective therapy of liver metastases in MTC patients are limited to… read more here.
Keywords: medullary thyroid; trans arterial; metastatic medullary; liver ... See more keywords
Metastatic medullary thyroid carcinoma: a new way forward
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine-Related Cancer"
DOI: 10.1530/erc-21-0368
Abstract: Medullary thyroid carcinoma (MTC) is a rare malignancy comprising 1–2% of all thyroid cancers in the United States. Approximately 20% of cases are familial, secondary to a germline RET mutation, while the remaining 80% are… read more here.
Keywords: thyroid carcinoma; carcinoma new; new way; medullary thyroid ... See more keywords
Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the United States.
Sign Up to like & getrecommendations! Published in 2023 at "Personalized medicine"
DOI: 10.2217/pme-2022-0050
Abstract: Aim: To describe real-world testing patterns for RET in US patients with advanced/metastatic medullary thyroid cancer and determine consistency of real-world testing practices with national guidelines. Materials & methods: The authors performed a retrospective medical… read more here.
Keywords: thyroid cancer; metastatic medullary; advanced metastatic; medullary thyroid ... See more keywords